ArticleJournal of translational medicine2015

Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.

Woan-Ruoh Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.